Access cutting-edge hiv-1 treatment through this clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.
Access hiv-1 specialists in Tampa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hiv-1 treatment provided free
The goal of this clinical study is to learn about the safety and tolerability of bictegravir/lenacapavir (BIC/LEN) and to learn how the study drug interacts with the body in virologically suppressed (VS) children and adolescents with human immunodeficiency virus type 1 (HIV-1) on a stable and complex antiretroviral (ARV) regimen. The study will also assess the safe loading dose of LEN and pharmacokinetics (PK) of BIC/LEN. The primary objectives of this study are: * To evaluate the steady-state
Sponsor: Gilead Sciences
Check if you qualify for this hiv-1 clinical trial in Tampa, FL
If you're searching for hiv-1 treatment options in Tampa, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tampa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv-1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.